Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 1998

View Archived Issues

Novalon signs research agreement with Millennium

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Protein Design Labs grants patent license to Genentech

Medarex and Novartis licensing agreement for HuMAb-Mouse technology

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

rHuIL-4 safe in patients with RA; efficacy studies are indicated

HIT study confirms the benefits of raising HDL cholesterol levels

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Preclinical studies indicate OP-1 is effective three days after stroke

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Celecoxib studies continue to generate impressive efficacy and safety data

Prolifix and Chugai extend research collaboration

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

More news from AHA: azimilide prevents atrial fibrillation

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Na+/Ca2+ exchange inhibitors patented by Taisho

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Novel Astra compounds inhibit mast cell, neutrophil and eosinophil activation

Novel aldose reductase inhibitor produced by Corynebacterium

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Oxigene initiates phase I clinical trials of combretastatin

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Pegylated interferon proves superior to standard interferon for treatment of HCV

BTG to commercialize new approach to bacterial vaccines

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...